Successful Everolimus Therapy for Atrioventricular Block Due to Cardiac Rhabdomyoma Associated With Tuberous Sclerosis Complex.

BACKGROUND

Cardiac rhabdomyoma (CR) associated with the tuberous sclerosis complex can cause atrioventricular (AV) block (AVB) by compressing the AV node. Everolimus, an mTOR inhibitor, is known to shrink these tumors and alleviate obstruction and tachycardia; however, improvement in AVB has not been previously described.

CASE SUMMARY: A 25-year-old woman was found to have a fetus with subependymal nodules and multiple CRs. After birth, an electrocardiogram demonstrated a persistent 2:1 AVB with a ventricular rate of 60 to 70 beats/min. Echocardiography revealed CRs, including one near the AV node. Everolimus was initiated before considering permanent pacemaker implantation. CRs regressed on echocardiography, and the AVB resolved. After discontinuation of everolimus, no tumor regrowth was observed.

DISCUSSION: In this case, the AVB resolved with rhabdomyoma regression. Although permanent pacemaker implantation was initially considered, everolimus successfully prevented further therapy.

TAKE-HOME MESSAGE: Everolimus may be a therapeutic option for AVB due to CR compressing the AV node.